Prostate Cancer Research advocates for screening high-risk men starting at age 45, emphasizing the need for better tests. Despite prostate cancer causing more deaths in men than breast cancer in women, current screening methods in the UK remain insufficient. Olympic cyclist Sir Chris Hoy’s recent plea after his terminal diagnosis highlights gaps in early detection. The debate involves weighing the benefits of early treatment against the risks of over-diagnosis and unnecessary procedures. Current trials show mixed results, prompting calls for more research and updated NHS guidelines to help avert late-stage diagnoses.